Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Aug 2026.
- Largest single sale: $1.0M (6,880 shares) of Gilead Sciences on Aug 26, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Gilead Sciences (GILD) | Director | Oct 26, 2020 | Aug 27, 2026 |
| Carlyle Group Inc. (CG) | Director | Nov 3, 2015 | May 1, 2026 |
| Loews Corporation (L) | Former Director | Jan 2, 2014 | Mar 4, 2025 |
| West Pharmaceutical Services (WST) | Former Director | Jan 5, 2004 | Apr 4, 2016 |
| UnitedHealth Group (UNH) | Former EVP, UnitedHealth Group | Sep 21, 2007 | Jun 7, 2012 |
Also a director at
Carlyle Group Inc. (CG), Loews Corporation (L) (no filing in the last 18 months), West Pharmaceutical Services (WST) (no filing in the last 18 months)
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 26, 2026, Gilead Sciences: sold 18,000 shares for $2.7M, under a disclosed plan; 18,000 shares acquired by exercising options. 1 filing: 1
- May 1, 2026, Carlyle Group Inc.: 4,450 shares granted. 1 filing: 1
- Apr 30, 2026, Gilead Sciences: 1,146 shares granted. 1 filing: 1
- Nov 25, 2025, Carlyle Group Inc.: 12,906 shares given away. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.